Illumina, Inc. vs KLA Corp. — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while KLA Corp. trades at $206 (market cap $261.92B). The key difference: KLA Corp. is far larger — about 9× Illumina, Inc.'s market cap, and KLA Corp. pays a 0.46% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | KLAC | |
|---|---|---|
Market Cap | $29.12B | $261.92B |
Sector | Health | Technology |
52-Week High | $205.10 | $301.71 |
52-Week Low | $91.00 | $84.39 |
Enterprise Value | $30.48B | $263.17B |
Dividend Yield | — | 0.46% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →